Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival

Author： Wang Yin-Hua   Fan Lei   Wang Li   Zhang Run   Zou Zhi-Jian   Fang Cheng   Zhang Li-Na   Li Jian-Yong   Xu Wei  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.54, Iss.6, 2013-06, pp. : 1165-1170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn

By Herishanu Yair  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1125-1126

Informa Healthcare

Access to resources Recommend Favorite

Decreased expression levels of Nurr1 are associated with chronic inflammation in patients with type 2 diabetes

By                    

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5487-5493

Spandidos Publications

Access to resources Recommend Favorite

Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia

By Alonci A.  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1336-1339

Humana Press, Inc

Access to resources Recommend Favorite

Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163

By                              

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1269-1278

Spandidos Publications

Access to resources Recommend Favorite

Monoclonal antibodies in the treatment of chronic lymphocytic leukemia

By Liu Nina   O’Brien Susan  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 297-304

Humana Press, Inc

Access to resources Recommend Favorite